Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2500${count})

  • GBA Biology and Therapies, 2018
    Link between LRRK2 Activity and Glucocerebrosidase Deficits in Idiopathic Parkinson’s Disease

    Study Rationale:
    Earlier work from this group reported greater LRRK2 activity in people with idiopathic (cause unknown) Parkinson’s. This project builds on those findings to investigate how that...

  • GBA Biology and Therapies, 2019
    Resolving the Pathophysiology of Parkinson's Disease with GBA Mutations

    Study Rationale:
    Mutations in the GBA gene are the greatest genetic risk factor for developing Parkinson’s disease (PD). We will systematically examine pathophysiological pathways in PD patients with...

  • GBA Biology and Therapies, 2018
    Analyzing Genetic Modifiers Using a CRISPR Activation/Inhibition GBA-PD Model

    Study Rationale:
    Clinical and genetic studies show that mutations in the GBA gene are risk factors for developing Parkinson’s disease (PD) and lead to an accumulation of glycolipids in the lysosome...

  • GBA Biology and Therapies, 2018
    Targeting GCase with Novel Pharmacological Chaperones

    Study Rationale:
    People who have mutations in the GBA gene have a higher chance of developing Parkinson's disease (PD). The GBA gene encodes the glucerebrosidase (GCase) protein, an enzyme located...

  • GBA Biology and Therapies, 2018
    Impact of Genetic Variants in GBA on Parkinson’s Disease

    Study Rationale:
    Changes to the DNA sequence are risk factors for Parkinson’s disease. While we know where many of these changes occur in our DNA, we still do not know how they cause Parkinson’s...

  • GBA Biology and Therapies, 2019
    Identification of Targets of Neurotoxic Sphingolipids Using iPSCs from People with GBA-associated Parkinson’s Disease

    Study Rationale:
    GBA encodes the enzyme beta-glucocerebrosidase (GCase), which is required to maintain function of the cell’s lysosomes, which break down unnecessary cellular parts. Mutations in GBA...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.